Home
Conditions
Diabetes Insipidus, Neurogenic

Clinical trial condition

Diabetes Insipidus, Neurogenic

Explore clinical trials studying Diabetes Insipidus, Neurogenic. Study availability and eligibility vary by location and protocol.

23 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Insipidus, Neurogenic trial results

Not Yet Recruiting

Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children

NCT06604975

Conditions: Behavior, Behavioral Symptoms, Central Diabetes Insipidus, +18 more
Locations: CHU Angers Angers, France

CHU de Bordeaux Bordeaux, France

CHU Lille Lille, France

HCL Lyon, France

View all 14 locations

View Trial Details

Completed

Identifying Oxytocin Deficiency in Adults With Pituitary Disease

NCT06460948

Conditions: Arginine Vasopressin Deficiency, Diabetes Insipidus, Diabetes Insipidus, Neurogenic, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

NCT04897802

Conditions: Behavior, Brain Diseases, Central Diabetes Insipidus, +21 more
Locations: Hospital de la Santa Creu i Sant Pau Barcelona, Spain

View Trial Details

Completed

Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)

NCT06542198

Conditions: Arginine Vasopressin Deficiency, Behavior, Behavioral Symptoms, +17 more
Locations: University Hospital Basel Basel, Switzerland

View Trial Details

Completed

Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia Syndrome

NCT05890690

Conditions: Arginine Vasopressin Deficiency, Behavior, Behavioral Symptoms, +16 more
Locations: University Hospital Basel Basel, Switzerland

View Trial Details

Completed

Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)

NCT05319301

Conditions: Behavior, Brain Diseases, Central Diabetes Insipidus, +27 more
Locations: Hospital de la Santa Creu i Sant Pau Barcelona, Spain

View Trial Details

Completed

Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)

NCT04902235

Conditions: Behavior, Brain Diseases, Central Diabetes Insipidus, +21 more
Locations: Hospital de la Santa Creu i Sant Pau Barcelona, Spain

View Trial Details

Completed

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

NCT03110133

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Difficile Infection Recurrence, +13 more
Locations: Scottsdale Scottsdale, Arizona, United States

Los Angeles Los Angeles, California, United States

Murrieta Murrieta, California, United States

Oakland Oakland, California, United States

View all 58 locations

View Trial Details

Completed

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

NCT03497806

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, C. Diff, +23 more
Locations: Scottsdale Scottsdale, Arizona, United States

Los Angeles Los Angeles, California, United States

Murrieta Murrieta, California, United States

Oakland Oakland, California, United States

View all 57 locations

View Trial Details

Completed

Copeptin After a Subcutaneous Stimulation With Glucagon in Adults

NCT04550520

Conditions: Behavior, Behavioral Symptoms, Diabetes Insipidus, +14 more
Locations: Divison of Endocrinology, Diabetes and Metabolism,University Hospital Basel Basel, Switzerland

View Trial Details

Diabetes Insipidus, Neurogenic

Diabetes Insipidus, Neurogenic trial results

Related conditions